Sinovac Update on the Exchange of Rights for Common and Series B Preferred Shares
BEIJING--(BUSINESS WIRE)--Apr 12, 2019--Sinovac Biotech Ltd. (NASDAQ:SVA) ("Sinovac" or the "Company"), a leading provider of biopharmaceutical products in China, today provided an…
